Symposien
Wenn Sie kostenlos an einer Veranstaltung teilnehmen wollen, melden Sie sich bitte hier an.
kommende Termine:
VIRAL NRW wünscht eine schöne Ferienzeit. Im Herbst sind wir wieder mit spannenden Veranstaltungen für Sie da.
Abbildung erstellt mit KI.
Hier finden Sie Informationen zu unseren vergangenen VIRAL Symposien
Comparison of Flu Viruses: Why Some Influenza Viruses Are More Dangerous Than Others
30. Symposium (27.03.2026): Dr. Martina Anzaghe, Paul-Ehrlich Institut
Computational prioritization of defective viral genomes for innovative antiviral therapies
29. Symposium (06.03.2026): Prof. Dr. Tanja Laske, Leibniz-Institut für Virologie, Hamburg
Conformational flexibility and molecular plasticity in herpesvirus entry and egress
28. Symposium ( 16.01.2026): Prof. Dr. Kay Grünewald, CSSB Centre for Structural Systems Biology, Hamburg
From in-silico to in-cellulo: Illuminating viral morphogenesis
27. Symposium (14.11.2025): Prof. Dr. Jens Bosse, Quantitative Virology, Institute of Virology, Hannover Medical School
Highly pathogenic Coronaviruses: from origin to intervention
26. Symposium (11.07.2025): Prof. Dr. Marcel Müller, Institute of Virology, Charité University Hospital Berlin
HPAIV H5N1 – from panzootic to pandemic?
25. Symposium (13.06.2025): Prof. Dr. Martin Beer, Friedrich-Loeffler-Institute
A disease ecology perspective on arthropod-borne viruses – insights from studies from Africa and Germany
24. Symposium (23.05.2025): Prof. Dr. Sandra Junglen, Institute of Virology, Charité – Universitätsmedizin, Berlin
How the anti-HCV immune response can drive lymphoma development
23. Symposium (09.05.2025): Dr. Christoph Schultheiss, Lab of Translational Immuno-oncology, Department of Biomedicine, University Hospital and University of Basel
Advancing Wastewater-Based Epidemiology and Preparedness: Developing a Toolbox for Detecting Circulating and Emerging Humanpathogenic Viruses
22. Symposium (21.02.2025): Dr. Marek Widera, Institut für medizinische Virologie, Universitätsmedizin Frankfurt
Mutational drivers in SARS-CoV-2 and other vertebrate RNA viruses – re-thinking virus evolution?
21. Symposium (07.02.2025): Prof. Dr. Peter Simmonds, Nuffield Department of Medicine, University of Oxford
In situ cryo-ET reveals influenza A virus assembly and vRNP interactions with hemagglutinin-remodelled membranes
20. Symposium (08.11.2024): Dr. Petr Chlanda, Department of Virology, Centre for Infectiology, Universitätsklinikum Heidelberg
Replication organelles of coronaviruses and other nidoviruses
19. Symposium (27.09.2024): Prof. Dr. Eric Snijder, Leiden University Center of Infectious Diseases, Leiden University Medical Centre
Sex differences in immunity and vaccination
18. Symposium (26.04.2024): Prof. Dr. Marylyn Addo, Zentrum für Innere Medizin, Hamburg
Development of broadly protective influenza virus vaccines
17. Symposium (08.03.2024): Prof. Dr. Florian Krammer, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York
Bunyavirus genome replication and transcription – a structural perspective
16. Symposium (23.02.2024): Dr. Maria Rosenthal, Department of Virology; Bernhard Nocht Institute for Tropical Medicine, Hamburg
Cytomegalovirus US11 and MHC-A, engaged in a coevolutionary arms race in hominids
15. Symposium (02.02.2024): Dr. Anne Halenius, Institute of Virology; University hospital Freiburg
Preparing the battle field – how cells remain vigilant against viral intruders
14. Symposium (17.11.2023): Dr. Marco Binder, Research Group: Dynamics of early viral infection and the innate antiviral response; German Cancer Research Center; Heidelberg
The journey from pandemic to endemic so far – Functional impact of adaptations in non-Spike genes of SARS-CoV-2
13. Symposium (20.10.2023): Prof. Dr. Konstantin Sparrer, Institute of molecular virology, university hospital Ulm
A new class of potent neutralizing human monoclonal antibodies targeting the Hepatitis E virus ORF2 protein
and
Pro- and antiviral host factors of hepatitis E virus entry
12. Symposium (09.06.2023):
Prof. Dr. Thomas Krey, Institute of Biochemistry, University of Lübeck: A new class of potent neutralizing human monoclonal antibodies targeting the Hepatitis E virus ORF2 protein
Dr. Volker Kinast, Medizinische Mikrobiologie und Virologie, Carl von Ossietzky Universität Oldenburg: Pro- and antiviral host factors of hepatitis E virus entry
Sex differences in SARS-CoV-2 pathogenesis
and
The ubiquitination landscape of the influenza A virus polymerase
11. Symposium (05.05.2023):
Prof. Dr. Gülsah Gabriel, Leibniz-Institut für Virologie (LIV), Hamburg: Sex differences in SARS-CoV-2 pathogenesis
Dr. Linda Brunotte, Westfälische Wilhelms-Universität, Münster: The ubiquitination landscape of the influenza A virus polymerase
Monkeypox: Past, present and future
10. Symposium (16.12.2022): Prof. Dr. Denisa Bojkova, Institut für Medizinische Virologie, Universitätsklinikum Frankfurt
Human herpesvirus diversity is altered in HLA class I binding peptides
and
Herbal medicines and UV-radiation to combat SARS-CoV-2
9. Symposium (30.09.2022):
Prof. Dr. William Palmer, Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, USA: Human herpesvirus diversity is altered in HLA class I binding peptides
Dr. Adalbert Krawczyk, Clinic for Infectiology, Medical Research Center, University Hospital Essen, Herbal medicines and UV-radiation to combat SARS-CoV-2.
Chasing the next SARS-CoV-2 variant and preparing for disease X
8. Symposium (16.09.2022): Prof. Dr. Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Hôpitaux Universitaires de Genève, Université Geneva
Investigation of the role of T cells in SARS-CoV-2 infection of non-human primates.
and
NK cell immune modulation by SARS-CoV-2
7. Symposium (11.03.2022):
Dr. Kim Hasenkrug, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton (USA): Investigation of the role of T cells in SARS-CoV-2 infection of non-human primates.
Wiebke Moskorz, Institut für Virologie, Düsseldorf: NK cell immune modulation by SARS-CoV-2.
Mutations in the spike protein of emerging SARS-CoV-2 variants affect cell tropism and neutralization sensitivity
and
Interfering with coronavirus infection – the role of type I IFN signaling for coronavirus immune control
6. Symposium (11.02.2022):
Dr. Markus Hoffmann, Deutsches Primatenzentrum, Leibniz-Institut für Primatenforschung, Göttingen: Mutations in the spike protein of emerging SARS-CoV-2 variants affect cell tropism and neutralization sensitivity
Dr. Stephanie Pfänder, Abteilung für Molekulare und Medizinische Virologie, Bochum: Interfering with coronavirus infection – the role of type I IFN signaling for coronavirus immune control
SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements
and
T cell responses in SARS-CoV-2 infections
5. Symposium (10.12.2021):
Dr. Jez Marston, Division of Infectious Diseases, New York: SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Prof. Dr. Sebastian Voigt, Institute for Virology, Essen: T cell responses in SARS-CoV-2 infections.
The Legacy of Covid-19 in Education
and
Lolli-Method to screen for SARS-CoV-2 Infection in Children
4. Symposium (19.11.2021):
Prof. Dr. Ludger Woessmann, ifo Zentrums für Bildungsökonomik, Ludwig-Maximilians-Universität München: The Legacy of Covid-19 in Education.
Dr. Felix Dewald, Institut für Virologie, Universität zu Köln: Lolli-Method to screen for SARS-CoV-2 Infection in Children.
Social determinants of COVID-19 (prevention, infection, disease severity): theory and empirical findings
3. Symposium (01.10.2021): Prof. Dr. Nico Dragano, Institut für medizinische Soziologie, Universitätsklinikum Düsseldorf
Aerosolprozesse und ihre Rolle bei der Übertragung von SARS-CoV-2
and
Stability and Inactivation of Corona viruses
2. Symposium (27.08.2021):
Prof. Dr. Andreas Held, Fachgebiet Umweltchemie und Luftreinhaltung der TU Berlin: Aerosolprozesse und ihre Rolle bei der Übertragung von SARS-CoV-2.
Dr. Stephanie Pfänder, Abteilung für Molekulare und Medzinische Virologie, Universität Bochum: Stability and Inactivation of Corona viruses.
SARS-CoV-2 evolution and immune evasion
and
T cell responses in acute and recovered COVID-19 patients
1. Symposium (25.06.2021):
Prof. Dr. Andreas Bergthaler, Research Center for Molecular Medicine of the Austrian Academy of Sciences Wien: SARS-CoV-2 evolution and immune evasion.
Prof. Dr. Ulf Dittmer, Institut für Virologie, Universität Duisburg-Essen: T cell responses in acute and recovered COVID-19 patients.
Möchten Sie Kontakt aufnehmen zu unseren Netzwerkpartnern? Kontaktieren Sie uns gerne!